APA (7th ed.) Citation

Heinzl, N., Maritschnegg, E., Koziel, K., Schilhart-Wallisch, C., Heinze, G., Yang, W., . . . Zeillinger, R. (2023). Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium. Oncogene, 42(33), 2473-2484. https://doi.org/10.1038/s41388-023-02758-8

Chicago Style (17th ed.) Citation

Heinzl, Nicole, et al. "Amyloid-like P53 as Prognostic Biomarker in Serous Ovarian Cancer—a Study of the OVCAD Consortium." Oncogene 42, no. 33 (2023): 2473-2484. https://doi.org/10.1038/s41388-023-02758-8.

MLA (9th ed.) Citation

Heinzl, Nicole, et al. "Amyloid-like P53 as Prognostic Biomarker in Serous Ovarian Cancer—a Study of the OVCAD Consortium." Oncogene, vol. 42, no. 33, 2023, pp. 2473-2484, https://doi.org/10.1038/s41388-023-02758-8.